StonvexLoading…
StonvexStonvexStonvexCore line items from SBAC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $244.50M | $152.87M | $194.65M | $296.88M |
Operating Income | $1.34B | $1.44B | $923.66M | $925.41M |
Net Income | $1.05B | $749.54M | $501.81M | $461.43M |
EPS (Diluted) | $9.80 | $6.94 | $4.61 | $4.22 |
Total Assets | $11.58B | $11.42B | $10.18B | $10.59B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $264.57M | $189.84M | $208.55M | $143.71M |
Free Cash Flow OCF − CapEx | $1.07B | $1.11B | $1.31B | $1.07B |
Shares Outstanding | 105.67M | 107.56M | 108.05M | 108.00M |